Health Innovation Manchester publishes Impact Report for 2022-23

Health Innovation Manchester has published its Annual Impact Report for 2022-2023, showcasing the breadth of innovation activity that has taken place across Greater Manchester’s health and care system over the last year.

Health Innovation Manchester, now in its 6th year, continues to work on behalf of GM health and care and academic system partners to discover, develop and deploy innovation aligned to the needs of GM citizens, as well as supporting economic development across the city region.

Within this impact report, we highlight through data, case studies and expert opinion how we are delivering a diverse programme of work to transform care pathways and support service improvements.

The report features a spotlight on each of Health Innovation Manchester’s key pillars: Digital Transformation, Innovation Development and Deployment, Research and Academia, and Industry Partners.

Read the HInM Annual Impact Report 2022-2023Click on each pillar below to see key highlights from the report.

We continue to drive digital transformation across Greater Manchester’s Integrated Care System including digital solutioning, design, delivery and coordinating the rollout of new digital programmes across the health and care system. Key highlights for 2022-23 include:

  • Welcome to Dr Gareth Thomas, who joined the Greater Manchester health and care system in 2023 as Digital Innovation Director.
  • How the GM Care Record is helping to transform care pathways and deliver more intelligence on the health and care needs of the population.
  • Why Greater Manchester’s Secure Data Environment will be able to answer deeper questions about the region’s health and care beyond the pandemic.
  • The rollout of Hospital at Home across Greater Manchester, a service which allows patients to get the care they need at home safely and conveniently, rather than being in hospital.

Development and deployment of innovation into practice using a range of capabilities including project management, business analysis, system engagement, public and clinical engagement, communications, evaluation and benefits realisation. Key highlights for 2022-23 include:

  • The Patient Safety Collaborative (PSC) team at Health Innovation Manchester have been delivering a range of projects to support the adoption and spread of proven innovations into health and care services, improving service efficiency, clinical practice and patient outcomes.
  • Our work with national partners on a range of projects to spread innovation at pace and scale, including the early intervention of eating disorders, improving the diagnosis of ADHD, preventing and supporting the management of cardiovascular disease, the Rapid Uptake Products (RUP) programme, and getting the balance right in polypharmacy.
  • How the Innovation for Healthcare Inequalities Programme (InHIP) is addressing local healthcare inequalities experienced by deprived and other under-served populations in Greater Manchester.

Operation of the academic health science centre, fostering academic partnerships, NIHR ARC-GM delivery and delivery of research domain-led projects. Key highlights for 2022-23 include:

  • How research undertaken via the Manchester Academic Health Science Centre (MAHSC) and GM’s other research bodies continue to be pulled through HInM’s innovation pathway to provide a rich pipeline of evidence-based innovations that can be deployed at pace and scale.
  • How NIHR ARC-GM is working with partners across the region to produce world-class research that is relevant, useful and applicable to local service needs and affects policy and practice within Greater Manchester and beyond.

Developing and delivering an industry strategy to maximise local benefits from industry capability and capacities, including partnerships with global and UK life sciences, med tech, digital and SMEs. Key highlights for 2022-23 include:

  • An update on how we are transforming asthma care and outcomes in Greater Manchester
  • How support of SMEs and industry partners, through our Innovation Nexus portal and a wide range of commercial support programmes including the R&I Health Accelerator programme, has aided the development of new products, technologies and innovative solutions that are ready for deployment.
  • Announcement of the launch of a new multi-million pound health innovation accelerator focused on rapidly improving the diagnosis and treatment of disease across the 2.8m GM population.

Professor Ben Bridgewater, Chief Executive at Health Innovation Manchester, and Rowena Burns, Chair at Health Innovation Manchester, said within the report: “Through our three-year business plan, ‘Leading with Delivery’, our ambition in making Greater Manchester a leading region to attract and deploy new innovations continues to grow. As we look forward to 2023-24 and beyond, we will continue to work closely with our partners to focus and deploy innovations at scale that will make the biggest difference to the health, wealth and wellbeing of our citizens.”

Back to top